High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: In vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain

This publication has 24 references indexed in Scilit:

• Amphetamine‐stimulated dopamine release competes in vivo for [¹²³I]IBZM binding to the D2 receptor in nonhuman primates
  Synapse, 1992
• High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors
  Life Sciences, 1991
• NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors
  Psychopharmacology, 1991
• Endogenous dopamine lowers the dopamine D₂ receptor density as measured by [³H]raclopride: Implications for positron emission tomography of the human brain
  Synapse, 1989
• In vivo [³H]Spiperone Binding: Evidence for Accumulation in Corpus Striatum by Agonist-Mediated Receptor Internalization
  Journal of Cerebral Blood Flow & Metabolism, 1988
• PET measurement of D2 and S2 receptor binding of 3-N-([2?-18F]fluoroethyl)spiperone in baboon brain
  European Journal of Nuclear Medicine and Molecular Imaging, 1988
• [3H]Spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis
  Brain Research, 1987
• Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity
  Journal of Cerebral Blood Flow & Metabolism, 1986
• Characteristics of specific in vivo labeling of neuroleptic binding sites with 3-N-[11C]methylspiperone
  European Journal of Nuclear Medicine and Molecular Imaging, 1986
• LIGAND: A versatile computerized approach for characterization of ligand-binding systems
  Analytical Biochemistry, 1980